Pnc Financial Services Group, Inc. Syndax Pharmaceuticals Inc Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,411 shares of SNDX stock, worth $38,792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,411
Previous 1,509
59.77%
Holding current value
$38,792
Previous $30,000
53.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SNDX
# of Institutions
227Shares Held
88.3MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$127 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$94 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$80.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$78.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$66.1 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $910M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...